Retina stem cells, hopes and obstacles

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Cell Biology

Background:

• Retinal degeneration causes significant visual impairment globally.
• Loss of retinal pigment epithelial (RPE) and photoreceptor cells drives pathogenesis.
• Current therapies offer limited success in preventing degeneration.

Purpose of the Study:

• To review preclinical and clinical stem cell (SC) strategies for retinal degeneration.
• To analyze SC types, efficacy, safety, and integration for cell replacement therapy.
• To identify challenges and future directions in SC-based vision restoration.

Main Methods:

• Literature review of preclinical studies and clinical trials.
• Analysis of various stem cell types: retinal progenitor cells (RPCs), embryonic SC, pluripotent SCs (PSCs), induced PSCs (iPSCs), and mesenchymal stromal cells.
• Evaluation of key outcomes: efficacy, safety, cell attachment, integration, tumorigenicity, and immunorejection.

Main Results:

• Two primary approaches focus on RPE or photoreceptor replacement.
• RPCs and iPSCs emerge as promising candidates due to low immunorejection and ethical considerations.
• Clinical trials indicate safety and efficacy, though challenges like tumorigenicity and integration persist.

Conclusions:

• Stem cell transplantation holds significant potential for treating retinal degeneration.
• RPCs and iPSCs represent the most viable options for future therapies.
• Continued research is crucial to overcome remaining hurdles for safe and effective vision restoration.